The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Original Article

Over-the-Counter Therapies for Urinary Incontinence before Presentation at a Specialty Clinic: Patient Perspective and Use

Authors: Megan Escott, MD, MS, Maya Fisher, BS, Katherine L. Woodburn, MD

Abstract

Objectives: The estimated prevalence of female urinary incontinence (UI) is 60% in the United States, and several over-the-counter (OTC) therapies for bladder health and UI exist on the market. Safety, efficacy, and patient use profiles of OTC treatment for medical issues such as constipation and headache are well established; however, research on OTC treatment of female UI before specialist presentation is sparse. The goal of this study was to characterize patient use of and attitudes toward OTC therapies for UI.

Methods: We developed an institutional review board–approved patient survey capturing demographic information and characterization of OTC therapy use. New patients presenting with a complaint of UI to the urogynecology providers at a tertiary care center were eligible for the study. Data analysis consisted of analyzing trends in participant responses.

Results: Forty-five survey responses were collected as a convenience sample over 8 weeks. Two-thirds of patients experienced UI for more than 2 years before seeing a specialist; 87% of patients reported moderate or severe UI according to Sandvik’s UI severity index. Two participants tried an OTC medication for UI and 17 tried pelvic floor exercises or devices. Sixty-two percent reported that they did not know any OTC treatments existed, and 71% believed healthcare providers were knowledgeable about OTC treatment and would be more likely to try these if recommended by their healthcare provider.

Conclusions: In a small sample of women with predominately moderate and severe UI, only 4% of patients tried OTC medications before specialist presentation despite two-thirds of patients experiencing symptoms for more than 2 years. Most respondents did not know that OTC treatments existed, but they said that would be likely to try them if recommended by a healthcare provider. This survey-based study highlights the lack of patient awareness about OTC therapies for female UI and the need for provider knowledge on this topic.
Posted in: Obstetrics and Gynecology88

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Aoki Y, Brown HW, Brubaker L, et al. Urinary incontinence in women. Nat Rev Dis Primers 2017;3:17042.
 
2. Forde JC, Chughtai B, Cea M, et al. Trends in ambulatory management of urinary incontinence in women in the United States. Female Pelvic Med Reconstr Surg 2017;23: 250–255.
 
3. Lukacz ES, Santiago-Lastra Y, Albo ME, et al. Urinary incontinence in women: a review. JAMA 2017;318:1592–1604.
 
4. Minassian VA, Yan X, Lichtenfeld MJ, et al. The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J 2012;23:1087–1093.
 
5. Rao SSC, Brenner DM. Efficacy and safety of over-the-counter therapies for chronic constipation: an updated systematic review. Am J Gastroenterol 2021;116:1156–1181.
 
6. AlShammari M, Assiri G, Bin Buraykan M, et al. The impact of direct-to-consumer pharmaceutical advertising on public knowledge of gastroesophageal reflux disease: a study on over-the-counter proton pump inhibitors. Patient Prefer Adherence 2020;14:635–642.
 
7. Peck J, Urits I, Zeien J, et al. A comprehensive review of over-the-counter treatment for chronic migraine headaches. Curr Pain Headache Rep 2020;24:19.
 
8. Sheikh I, Waghray A, Waghray N, et al. Consumer use of over-the-counter proton pump inhibitors in patients with gastroesophageal reflux disease. Am J Gastroenterol 2014;109: 789–794.
 
9. Duenas-Garcia OF, Shapiro RE, Gaccione P. Safety and efficacy of a disposable vaginal device for stress urinary incontinence. Female Pelvic Med Reconstr Surg 2021;27:360–364.
 
10. Lefterova A, Getov I. Study on consumers’ preferences and habits for over-the-counter analgesics use. Cent Eur J Public Health 2004;12:43–45.
 
11. Schwartz MP, Wagner PJ. Which medicines do our patients want from us? J Fam Pract 2000; 49:339–341.
 
12. Omosigho U, Holt EW, Murarka S, et al. Provider practice patterns regarding over-the-counter continence devices. Int Urogynecol J 2024;35:995–1000.
 
13. Cho ST, Kim KH. Pelvic floor muscle exercise and training for coping with urinary incontinence. J Exerc Rehabil 2021;17:379–387.
 
14. Nucifora J, Howard Z, Weir KA. Do patients discharged from the physiotherapy-led pelvic health clinic re-present to the urogynaecology service? Int Urogynecol J 2022;33:689–695.
 
15. Sandvik H, Hunskaar S, Seim A, et al. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health (1978) 1993;47:497–499.